Clinical Trial Update: A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808) [Phase 3]

View source ↗

Summary

Phase 3 trial status update for MK0653A in patients with hypercholesterolemia hospitalized for a possible heart problem; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MK0653A

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED